BRTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BioRestorative Therapies Inc (BRTX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock exhibits weak financial performance, no positive trading trends, and lacks significant catalysts or signals to suggest a strong entry point. Additionally, the technical indicators show bearish trends, and the stock's recent price movement is negative.
The MACD is slightly positive at 0.0134, but the RSI is neutral at 25.568, indicating no clear bullish momentum. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels (Pivot: 0.244, Current Price: 0.21). The overall technical outlook is bearish.
NULL. No recent news, congress trading, or influential figure activity. No significant hedge fund or insider trading trends.
The stock price has been declining (-3.17% in regular market, -0.23% post-market), and financials show a significant YoY revenue drop (-94.95%) and weak gross margin (-88.70% YoY).
In Q3 2025, revenue dropped significantly (-94.95% YoY) to $11,800. Net income improved but remains negative at -$3,038,277 (up 178.38% YoY). EPS improved to -0.33 (up 153.85% YoY), but gross margin fell sharply (-88.70% YoY) to 10.42. Overall, the financials indicate poor growth and profitability.
No analyst rating or price target changes available.
